Developmental Biology Program
The Lorenz Studer Lab
Research
Professor
Our laboratory aims at exploiting recent advances in stem cell biology to develop radically new therapies for degenerative disease and cancer. The main focus in the lab is on the biology and application of human embryonic stem (ES) and human induced pluripotent (iPS) cells. Pluripotent stem cells can provide a truly unlimited source for deriving therapeutically relevant cell types for applications in human disease modeling or regenerative medicine.
Research Projects
Featured News
People
Lorenz Studer, MD
Director, Center for Stem Cell Biology
Professor
- The Studer laboratory investigates human stem cells as tools to understand normal and pathological development in the nervous system and to develop cell-based strategies for regenerative medicine.
- MD, Universitat Bern
- [email protected]
- Email Address
- 212-639-6126
- Office Phone
Members
- BS, Cornell University
- Cancer Biology
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- 212-639-8510
- Lab Phone
- Princeton University
- Connecticut College
- Wellesley College
Achievements
- Member, National Academy of Medicine (2024)
- Helis Foundation Prize for Parkinson’s disease and Neurodegenerative Research, John’s Hopkins University (2024)
- ISSCR Achievement Award (2022)
- ISSCR, Ernest McCulloch Memorial Lecture, Robert & Claire Pasarow Foundation Award (2019)
- Jacob & Louise Gabbay Award in Biotechnology & Medicine (2018)
- Ogawa-Yamanaka Stem Cell Prize, Gladstone Institutes (2017)
- MacArthur Fellow (2015)
- Member, American Society of Clinical Investigation (2014)
- Annemarie Opprecht Parkinson Award, Annemarie Opprecht Foundation (2012)
- Louise and Allston Boyer Young Investigator in Basic Research, Memorial Sloan Kettering Cancer Center (2005)
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Career Opportunities
Get in Touch
-
Lab Head Email
-
Office Phone
-
Lab Phone
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Lorenz Studer discloses the following relationships and financial interests:
-
BlueRock Therapeutics
Intellectual Property Rights; Professional Services and Activities -
DaCapo Brainscience, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Fujifilm Cellular Dynamics, Inc.
Intellectual Property Rights -
Luxa Biotechnology, LLC
Professional Services and Activities
-
Roche
Professional Services and Activities -
Rumi Scientific, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Vita Therapeutics, Inc.
Equity; Professional Services and Activities (Uncompensated)
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].